GLP-3RT

GLP-3RT is a next-generation triple agonist peptide that activates the glucagon-like peptide-1 (GLP-1), glucose-dependent insulinotropic polypeptide (GIP), and Glucagon receptors.

Key Benefits:

• Substantial Weight Reduction: Clinical trials demonstrated large reductions in body weight and adiposity.

• Appetite Regulation: GLP-1 and GIP receptor activity reduces energy intake and increase satiety.

• Increased Energy Expenditure: Glucagon-receptor agonism increases metabolic energy expenditure.

• Fat Metabolism: Glucagon signaling promotes lipid mobilization and oxidation as part of retatrutide’s metabolic effects.

• Improved Glycemic Control: Incretin receptor activation enhances glucose-dependent insulin secretion and supports glucose regulation.

• Improved Insulin Sensitivity: Weight reduction and incretin activity can improve markers of insulin resistance and metabolic health.

Compound Class: Triple GLP-1/GIP/Glucagon receptor agonist

CAS Number: 2381089-83-2

Molecular Formula: C₂₂₁H₃₄₂N₄₆O₆₈

Molecular Weight: ~4,731.3 Da

Form: Lyophilized Powder

Storage: Store in a cool, dark environment away from light. Avoid repeated temperature swings.

• Lyophilized Powder Vial - Keep frozen between -2F to -4F

• Reconstituted Liquid Vial - Keep refrigerated between 36F to 40F. Do NOT freeze.

Disclaimer: These products are intended for research or laboratory use only. Not for human or veterinary consumption.

These statements have not been reviewed by the FDA nor are they medical advice. Retailer is not responsible for injury or death. Always consult with a licensed health professional for medical advice.